V-Square Quantitative Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
2,069
+119
+6% +$66.7K 0.1% 168
2026
Q1
$1.1M Buy
1,950
+13
+0.7% +$8.34K 0.12% 155
2025
Q4
$1.31M Buy
+1,937
New +$1.32M 0.14% 125
2025
Q3
Sell
-2,117
Closed -$1.14M 357
2025
Q2
$1.14M Sell
2,117
-12
-0.6% -$5.74K 0.15% 130
2025
Q1
$894K Buy
2,129
+53
+3% +$23K 0.13% 172
2024
Q4
$858K Buy
2,076
+121
+6% +$53.1K 0.12% 173
2024
Q3
$988K Buy
1,955
+83
+4% +$40.3K 0.15% 139
2024
Q2
$912K Buy
1,872
+59
+3% +$29.6K 0.15% 126
2024
Q1
$979K Buy
1,813
+332
+22% +$181K 0.14% 123
2023
Q4
$822K Buy
1,481
+366
+33% +$172K 0.15% 110
2023
Q3
$488K Buy
1,115
+458
+70% +$228K 0.21% 90
2023
Q2
$330K Sell
657
-32
-5% -$15.3K 0.24% 80
2023
Q1
$345K Buy
+689
New +$330K 0.32% 81

Other funds holding IDXX

V-Square Quantitative Management's IDXX Position: Q2 2026 in Review

V-Square Quantitative Management increased its Idexx Laboratories (IDXX) stake by 6.1% in Q2 2026, buying an estimated $66.7K and bringing the position to 2,069 shares worth $1.09M. The position accounts for 0.1% of the portfolio, ranked #168.

V-Square Quantitative Management first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.31M in Q4 2025. 459 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • V-Square Quantitative Management held 2,069 shares of Idexx Laboratories worth $1.09M as of Q2 2026.
  • V-Square Quantitative Management bought 119 Idexx Laboratories shares in Q2 2026, an estimated $66.7K.
  • Idexx Laboratories made up 0.1% of V-Square Quantitative Management's portfolio in Q2 2026, its #168 holding.
  • V-Square Quantitative Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • V-Square Quantitative Management's Idexx Laboratories position peaked at $1.31M in Q4 2025.
  • 459 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.